Description
Used in the treatment of:
- Severe osteoporosis in postmenopausal women and men at high risk of fracture
- Osteoporosis induced by long-term corticosteroid use
Teriparatide is a recombinant form of human parathyroid hormone (PTH 1-34) that stimulates bone formation, increases bone mineral density, and reduces fracture risk.



